Qm-2 Papaverine recalls
The FDA has published 2 recalls involving Qm-2 Papaverine since 2022. The latest was reported on 1 Jun 2022. Most were for manufacturing (cgmp) deviations. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2022
Last 12 months0reported
Class I00% of total
Ongoing0latest 1 Jun 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why qm-2 papaverine is recalled
Companies
By year
All qm-2 papaverine recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | QM-2 Papaverine 30 mg/mL Phentolamine 3 mg/mL Alprostadil recalled | Olympia Compounding Pharmacy | Sterility | Nationwide |
| Drug | CLASS II | QM-2 Papaverine 30 mg/mL. Phentolamine 3 mg/mL . recalled | Olympia Compounding Pharmacy | Manufacturing (CGMP) Deviations | Nationwide |
Should you stop taking Qm-2 Papaverine?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.